@Sambong @AlphaRR @Stocktwits_2018 @Seattledreamer not sure if you know about this company, Sambong, but it's definitely one (with ARWR) to put on your watchlist. DRNA ran far better than ARWR earlier in the year, then it fell back while ARWR has soared. But DRNA will close the share-price distance again, and I wouldn't be surprised to see it outperform on a relative basis. Two outstanding, cutting-edge companies in a cutting edge scientific space.